Literature DB >> 29237914

The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis.

Zhenhua Liu1, Haichao Huang2, Shaobo Li3, Wei Yu1, Wei Li2, Jie Jin1, Xin Li1, Jinchun Xing2.   

Abstract

OBJECTIVES: Albumin-globulin ratio (AGR) has been reported as an independent risk factor for survival outcomes of a variety of malignancies. We aimed to further examine the prognostic value of AGR for urothelial carcinoma of bladder (UCB) using a propensity score-matched (PSM) analysis.
MATERIALS AND METHODS: The medical data of 189 high-grade UCB patients undergoing radical cystectomy were retrospectively reviewed. AGR was defined as the ratio of serum albumin to nonalbumins (serum total protein-albumin). The association of preoperative AGR with clinicopathologic characteristics and prognosis were assessed. Multivariate analyses using Cox regression models were applied to evaluate the independent prognostic factors.
RESULTS: The receiver operating curve analysis indicated 1.55 as the optimal cutoff value to define low or high AGR. In prematched cohorts, Kaplan-Meier analysis indicated that AGR lower than 1.55 was associated with poorer overall survival (OS), progression-free survival (PFS), and tumor-specific survival (TSS) (P < 0.001 for all). Multivariable cox analyses also showed that AGR lower than 1.55 were an independent risk factor for survival outcomes, including OS, PFS, and TSS (P < 0.01 for all). In particular, AGR lower than 1.55 remained its prognostic value after PSM analysis.
CONCLUSION: Low AGR was a significant unfavorable factor for UCB patients treated with radical cystectomy. This viable parameter should be enrolled in the pretreatment risk stratification for UCB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29237914     DOI: 10.4103/jcrt.JCRT_237_17

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer.

Authors:  Akira Kawata; Ayumi Taguchi; Satoshi Baba; Yuichiro Miyamoto; Michihiro Tanikawa; Kenbun Sone; Tetsushi Tsuruga; Mayuyo Mori; Katsutoshi Oda; Kei Kawana; Yutaka Osuga; Tomoyuki Fujii
Journal:  Int J Clin Oncol       Date:  2021-01-21       Impact factor: 3.402

2.  Preoperative Inversed Albumin-to-Globulin Ratio Predicts Worse Oncologic Prognosis Following Curative Hepatectomy for Hepatocellular Carcinoma.

Authors:  Cheng-Cheng Zhang; Cheng-Wu Zhang; Hao Xing; Yu Wang; Lei Liang; Yong-Kang Diao; Ting-Hao Chen; Wan Yee Lau; Ping Bie; Zhi-Yu Chen; Tian Yang
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

3.  Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis.

Authors:  Yi Zhang; Lijuan Wang; Shibu Lin; Rong Wang
Journal:  Cancer Manag Res       Date:  2018-10-17       Impact factor: 3.989

4.  Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients.

Authors:  Xiaoyan Wang; Guodong Yang; Yumeng Chai; Zhouyue Li; Xuanyan Che; Yongqiang Wang; Liqing Yang; Zhongbao Zhou
Journal:  Dis Markers       Date:  2022-09-05       Impact factor: 3.464

5.  Prognostic value of pretreatment serum albumin-globulin ratio in urothelial carcinoma: A systematic review and meta-analysis.

Authors:  Zhongyou Xia; Xueqin Fu; Jinze Li; Ji Wu; Chao Niu; Yulai Xu; Hao Wang; Xinzhu Yuan; Lingtong Tang
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

6.  Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study.

Authors:  Satoru Taguchi; Taketo Kawai; Tohru Nakagawa; Yu Nakamura; Jun Kamei; Daisuke Obinata; Kenya Yamaguchi; Tomoyuki Kaneko; Shigenori Kakutani; Mayuko Tokunaga; Yukari Uemura; Yusuke Sato; Tetsuya Fujimura; Hiroshi Fukuhara; Yutaka Enomoto; Hiroaki Nishimatsu; Satoru Takahashi; Haruki Kume
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

7.  Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn's Disease Patients.

Authors:  Eun Sil Kim; Yiyoung Kwon; Yon Ho Choe; Mi Jin Kim
Journal:  Gut Liver       Date:  2022-01-15       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.